About Tandem Diabetes Care Inc
Ticker
info
TNDM
Trading on
info
NASDAQ
ISIN
info
US8753722037
Industry
info
Medical Devices
Sector
info
Healthcare
CEO
info
John F. Sheridan
Headquarters
info
12400 High Bluff Drive, San Diego, CA, United States, 92130
Employees
info
2,650
Website
info
tandemdiabetes.com
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Metrics
BasicAdvanced
Market cap
info
$1.12B
P/E ratio
info
-
EPS
info
-$2.79
Dividend Yield
info
0.00%
Beta
info
1.52
Forward P/E ratio
info
1,111.11
EBIDTA
info
$-75.1M
Ex dividend date
info
-
Price & volume
Market cap
info
$1.12B
Average daily volume
info
1.6M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
1,111.11
PEG ratio
info
0
Trailing P/E
info
0
Price to sales
info
1.14
Price to book
info
7.2
Earnings
EPS
info
-$2.79
EPS estimate (current quarter)
info
-$0.61
EPS estimate (next quarter)
info
-$0.36
EBITDA
info
$-75.1M
Revenues (TTM)
info
$983M
Revenues per share (TTM)
info
$14.96
Technicals
Beta
info
1.52
52-week High
info
$48.24
52-week Low
info
$15.75
50-day moving average
info
$20.41
200-day moving average
info
$28.41
Short ratio
info
6.31
Short %
info
18.46%
Management effectiveness
ROE (TTM)
info
-92.31%
ROA (TTM)
info
-6.17%
Profit margin
info
-18.71%
Gross profit margin
info
$513M
Operating margin
info
-14.71%
Growth
Quarterly earnings growth (YoY)
info
-37.00%
Quarterly revenue growth (YoY)
info
22.30%
Share stats
Outstanding Shares
info
66.6M
Float
info
61.5M
Insiders %
info
0.94%
Institutions %
info
111.59%
Analyst Insights & forecasts
info

49% Buy

47% Hold

4% Sell

Based on information from 21 analysts.

Average price target

info
$32.70
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.48
-$0.54
11.11%
Q2 • 24Beat
-$0.35
-$0.40
12.50%
Q3 • 24Beat
-$0.44
-$0.24
-84.81%
Q4 • 24Missed
-$0.67
-$0.61
-9.46%
Q1 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$283M
$0.8M
0.27%
Q4 • 24
$234M
$-131M
-55.69%
Q1 • 25
-17.06%
-17,392.19%
-20,949.59%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$968M
$705M
72.81%
Q4 • 24
$922M
$767M
83.16%
Q1 • 25
-4.70%
8.84%
14.21%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$10.7M
$5M
$2.3M
$-38.8M
Q4 • 24
$-18.3M
$9.2M
$-4.7M
$-21.2M
Q1 • 25
-270.55%
83.35%
-303.65%
-45.19%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Tandem Diabetes Care Inc share?
Collapse

Tandem Diabetes Care Inc shares are currently traded for undefined per share.

How many shares does Tandem Diabetes Care Inc have?
Collapse

Tandem Diabetes Care Inc currently has 66.6M shares.

Does Tandem Diabetes Care Inc pay dividends?
Collapse

No, Tandem Diabetes Care Inc doesn't pay dividends.

What is Tandem Diabetes Care Inc 52 week high?
Collapse

Tandem Diabetes Care Inc 52 week high is $48.24.

What is Tandem Diabetes Care Inc 52 week low?
Collapse

Tandem Diabetes Care Inc 52 week low is $15.75.

What is the 200-day moving average of Tandem Diabetes Care Inc?
Collapse

Tandem Diabetes Care Inc 200-day moving average is $28.41.

Who is Tandem Diabetes Care Inc CEO?
Collapse

The CEO of Tandem Diabetes Care Inc is John F. Sheridan.

How many employees Tandem Diabetes Care Inc has?
Collapse

Tandem Diabetes Care Inc has 2,650 employees.

What is the market cap of Tandem Diabetes Care Inc?
Collapse

The market cap of Tandem Diabetes Care Inc is $1.12B.

What is the P/E of Tandem Diabetes Care Inc?
Collapse

The current P/E of Tandem Diabetes Care Inc is null.

What is the EPS of Tandem Diabetes Care Inc?
Collapse

The EPS of Tandem Diabetes Care Inc is -$2.79.

What is the PEG Ratio of Tandem Diabetes Care Inc?
Collapse

The PEG Ratio of Tandem Diabetes Care Inc is 0.

What do analysts say about Tandem Diabetes Care Inc?
Collapse

According to the analysts Tandem Diabetes Care Inc is considered a buy.